Masami Kawamura

462 total citations
13 papers, 337 citations indexed

About

Masami Kawamura is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Masami Kawamura has authored 13 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Masami Kawamura's work include Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (6 papers) and CAR-T cell therapy research (5 papers). Masami Kawamura is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (6 papers) and CAR-T cell therapy research (5 papers). Masami Kawamura collaborates with scholars based in Japan, Germany and United States. Masami Kawamura's co-authors include Kanako Shimizu, Shin‐ichiro Fujii, Osamu Ohara, Haruhiko Koseki, Tarou Irié, Tomohiro Miyai, Shintaro Hojyo, Atsushi Hijikata, Manabu Nakayama and Tomokatsu Ikawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Masami Kawamura

13 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masami Kawamura Japan 8 148 124 89 82 81 13 337
Tomohiro Miyai Japan 6 254 1.7× 45 0.4× 43 0.5× 137 1.7× 117 1.4× 9 383
Koshi MORI Japan 8 209 1.4× 46 0.4× 46 0.5× 121 1.5× 93 1.1× 8 359
Tamara Korolnek United States 7 66 0.4× 41 0.3× 27 0.3× 28 0.3× 165 2.0× 7 395
Quan Shen China 10 98 0.7× 73 0.6× 38 0.4× 11 0.1× 178 2.2× 20 351
Vanessa Bach Spain 9 116 0.8× 16 0.1× 31 0.3× 52 0.6× 74 0.9× 12 260
Mami Matsuda‐Lennikov Japan 8 50 0.3× 117 0.9× 28 0.3× 9 0.1× 110 1.4× 11 291
Thirayost Nimmanon Thailand 8 162 1.1× 10 0.1× 51 0.6× 70 0.9× 85 1.0× 16 340
Jiang-yan Zhong China 8 68 0.5× 148 1.2× 41 0.5× 12 0.1× 186 2.3× 9 383
Katy Argentati Italy 9 32 0.2× 266 2.1× 88 1.0× 17 0.2× 70 0.9× 10 399
Bettina Bochow Germany 11 364 2.5× 37 0.3× 36 0.4× 285 3.5× 102 1.3× 12 574

Countries citing papers authored by Masami Kawamura

Since Specialization
Citations

This map shows the geographic impact of Masami Kawamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masami Kawamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masami Kawamura more than expected).

Fields of papers citing papers by Masami Kawamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masami Kawamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masami Kawamura. The network helps show where Masami Kawamura may publish in the future.

Co-authorship network of co-authors of Masami Kawamura

This figure shows the co-authorship network connecting the top 25 collaborators of Masami Kawamura. A scholar is included among the top collaborators of Masami Kawamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masami Kawamura. Masami Kawamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Okada, M., Satoru Yamasaki, Hiroshi Nakazato, et al.. (2024). ARID1A-Deficient Tumors Acquire Immunogenic Neoantigens during the Development of Resistance to Targeted Therapy. Cancer Research. 84(17). 2792–2805. 2 indexed citations
3.
Shimizu, Kanako, et al.. (2023). Combination of cancer vaccine with CD122-biased IL-2/anti-IL-2 Ab complex shapes the stem-like effector NK and CD8+ T cells against tumor. Journal for ImmunoTherapy of Cancer. 11(7). e006409–e006409. 7 indexed citations
4.
Fujii, Shin‐ichiro, Toyotaka Kawamata, Kanako Shimizu, et al.. (2022). Reinvigoration of innate and adaptive immunity via therapeutic cellular vaccine for patients with AML. Molecular Therapy — Oncolytics. 27. 315–332. 13 indexed citations
5.
Shimizu, Kanako, et al.. (2022). A single immunization with cellular vaccine confers dual protection against SARS‐CoV‐2 and cancer. Cancer Science. 113(8). 2536–2547. 6 indexed citations
6.
Fujii, Shin‐ichiro, et al.. (2021). Cancer immunotherapy using artificial adjuvant vector cells to deliver NY‐ESO‐1 antigen to dendritic cells in situ. Cancer Science. 113(3). 864–874. 13 indexed citations
7.
Shimizu, Kanako, Yusuke Sato, Masami Kawamura, et al.. (2019). Eomes transcription factor is required for the development and differentiation of invariant NKT cells. Communications Biology. 2(1). 150–150. 33 indexed citations
8.
Shimizu, Kanako, Satoru Yamasaki, Noriko Yumoto, et al.. (2019). Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFN. Frontiers in Immunology. 10. 1450–1450. 23 indexed citations
9.
Iyoda, Tomonori, Satoru Yamasaki, Masami Kawamura, et al.. (2019). Optimal therapeutic strategy using antigen‐containing liposomes selectively delivered to antigen‐presenting cells. Cancer Science. 110(3). 875–887. 5 indexed citations
10.
Yamasaki, Satoru, et al.. (2016). In vivo dendritic cell targeting cellular vaccine induces CD4+ Tfh cell-dependent antibody against influenza virus. Scientific Reports. 6(1). 35173–35173. 14 indexed citations
11.
Shimizu, Kanako, Jun Shinga, Satoru Yamasaki, et al.. (2015). Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT Cells. PLoS ONE. 10(6). e0131477–e0131477. 17 indexed citations
12.
Miyai, Tomohiro, Shintaro Hojyo, Tomokatsu Ikawa, et al.. (2014). Zinc transporter SLC39A10/ZIP10 facilitates antiapoptotic signaling during early B-cell development. Proceedings of the National Academy of Sciences. 111(32). 11780–11785. 108 indexed citations
13.
Hojyo, Shintaro, Tomohiro Miyai, Hitomi Fujishiro, et al.. (2014). Zinc transporter SLC39A10/ZIP10 controls humoral immunity by modulating B-cell receptor signal strength. Proceedings of the National Academy of Sciences. 111(32). 11786–11791. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026